Mirae Asset Global Investments’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.5K | Buy |
3,689
+634
| +21% | +$8.33K | ﹤0.01% | 1264 |
|
|
2025
Q1 | $44.6K | Buy |
3,055
+83
| +3% | +$1.21K | ﹤0.01% | 1258 |
|
|
2024
Q4 | $50.4K | Buy |
2,972
+416
| +16% | +$7.05K | ﹤0.01% | 1266 |
|
|
2024
Q3 | $40.4K | Buy |
2,556
+826
| +48% | +$13K | ﹤0.01% | 1338 |
|
|
2024
Q2 | $15.5K | Buy |
+1,730
| New | +$15.5K | ﹤0.01% | 1417 |
|
|
2022
Q3 | – | Sell |
-57,342
| Closed | -$703K | – | 2601 |
|
|
2022
Q2 | $703K | Buy |
+57,342
| New | +$703K | ﹤0.01% | 1588 |
|